VendorInvestigate result on a Nantong dulaglutide lot lands 0.9 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
The archive
Page 53 of 170 of this archive, newest first.
What the new Switzerland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The consolidator trading as Meridian Freight Partners closes after 21 years
A proper account of an operation that existed, and of what closing it cost.
How a claim degrades between the bench and the listing
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
The shortage years, and what they taught about interruption
Why the reason for stopping changes what happens afterwards.
STEP 1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a CPC cagrilintide lot at 98.4%, against 96.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
The quiet end of Halvard & Pike Apothecary of Portland, Maine
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 15 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Reproducibility, measured rather than assumed
The Journal submitted split samples from single lots to three assay services, under names unconnected to this publication, and published each method alongside each result.
Gallstones during rapid weight loss: drug, or weight loss?
Pancreatitis is rare, was adjudicated in the outcome programmes, and did not show the imbalance early case reports suggested.
The limits of mechanism: why receptor data will not tell you who responds
A catalogue of open questions, with an assessment of how likely each is to be resolved.
What a 25% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Calder Vale Peptides of Skipton closes after 9 years
A proper account of an operation that existed, and of what closing it cost.
The 14-day notice: how a compounding wind-down works in France
The document is four pages. Three of them are about dates.
Why a dry powder is a chemical reactor with the volume turned down
Residual moisture is measured routinely in regulated manufacture, is reported almost nowhere in this trade, and predicts long-term stability better than any other single…
What the new France guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
The online reseller trading as Adamant Research Supply closes after 22 years
A proper account of an operation that existed, and of what closing it cost.
South Africa health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
SELECT misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The intramuscular injection nobody intended
Skin thickness at the standard injection sites is approximately two millimetres in adults and varies remarkably little with body mass. That single finding is why short…
Continued treatment against continued placebo: the comparison that settled it
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
What a laboratory knows about the material it receives
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
Calder Vale Peptides of Skipton enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Poland caps liraglutide prescribing to 14 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at WWB in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The shortage years, and what they taught about interruption
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
Bacteriostatic water, sterile water, and the 0.9 per cent that makes the difference
An in-use period is established by a dedicated study on a specific formulation in a specific container at a specific concentration. Borrowing one from a marketed product is…
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.